Evidence map›Paper›PMID 29350269›Full record

ArticleInternational journal of legal medicine2018

Exome analysis in 34 sudden unexplained death (SUD) victims mainly identified variants in channelopathy-associated genes.

Jacqueline Neubauer, Maria Rita Lecca, Giancarlo Russo, Christine Bartsch, Argelia Medeiros-Domingo, Wolfgang Berger, Cordula Haas

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of legal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Genes · 2022
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jacqueline NeubauerZurich Institute of Forensic Medicine, Forensic Genetics, University of Zurich, Winterthurerstrasse 190/52, 8057, Zurich, Switzerland. jacqueline.neubauer@irm.uzh.ch.
Maria Rita LeccaFunctional Genomics Center Zurich (FGCZ), University of Zurich/ETH Zurich, Zurich, Switzerland.
Giancarlo RussoFunctional Genomics Center Zurich (FGCZ), University of Zurich/ETH Zurich, Zurich, Switzerland.
Christine BartschUniversity of Zurich, Zurich, Switzerland.
Argelia Medeiros-DomingoDepartment of Cardiology, Inselspital, University Hospital Bern, Bern, Switzerland.
Wolfgang BergerInstitute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland.
Cordula HaasZurich Institute of Forensic Medicine, Forensic Genetics, University of Zurich, Winterthurerstrasse 190/52, 8057, Zurich, Switzerland.
University of Zurich · CHETH Zurich · CHUniversity Hospital of Bern · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 320030_149456
6 · The paper itself

Abstract

Sudden cardiac death (SCD) is one of the major causes of mortality worldwide, mostly involving coronary artery disease in the elderly. In contrary, sudden death events in young victims often represent the first manifestation of undetected genetic cardiac diseases, which remained without any symptoms during lifetime. Approximately 30% of these sudden death cases have no definite cardiac etiology after a comprehensive medicolegal investigation and are therefore termed as sudden unexplained death (SUD) cases. Advances in high-throughput sequencing approaches have provided an efficient diagnostic tool to identify likely pathogenic variants in cardiovascular disease-associated genes in otherwise autopsy-negative SUD cases. The aim of this study was to genetically investigate a cohort of 34 unexplained death cases by focusing on candidate genes associated with cardiomyopathies and channelopathies. Exome analysis identified potentially disease-causing sequence alterations in 29.4% of the 34 SUD cases. Six (17.6%) individuals had variants with likely functional effects in the channelopathy-associated genes AKAP9, KCNE5, RYR2, and SEMA3A. Interestingly, four of these six SUD individuals were younger than 18 years of age. Since the total SUD cohort of this study included five children and adolescents, post-mortem molecular autopsy screening indicates a high diagnostic yield within this age group. Molecular genetic testing represents a valuable approach to uncover the cause of death in some of the SUD victims; however, 70-80% of the cases still remain elusive, emphasizing the importance of additional research to better understand the pathological mechanisms leading to a sudden death event.

Indexed as

ExomeAdolescentAdultA Kinase Anchor ProteinsChannelopathiesChildChild, PreschoolCohort StudiesCytoskeletal ProteinsDeath, Sudden, CardiacFemaleHigh-Throughput Nucleotide SequencingHumansInfantMaleMiddle AgedAKAP9 protein, humanA Kinase Anchor ProteinsCytoskeletal ProteinsKCNE5 protein, humanPotassium Channels, Voltage-GatedRyanodine Receptor Calcium Release ChannelRyR2 protein, humanSEMA3A protein, humanSemaphorin-3ACardiovascular diseasesChannelopathiesMolecular autopsySudden unexplained deathWhole-exome sequencing

Identifiers

PMID29350269
OpenAlexW2784855698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.